Accelerating response to antidepressant treatment in depression: A review and clinical suggestions

被引:54
|
作者
Nakajima, Shinichiro
Suzuki, Takefumi [2 ,3 ]
Watanabe, Koichiro
Kashima, Haruo
Uchida, Hiroyuki [1 ,2 ]
机构
[1] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo 1608582, Japan
[2] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
关键词
Antidepressant; Early non-response; Major depressive disorder; Predictor; Switching; SEROTONIN REUPTAKE INHIBITOR; TREATING MAJOR DEPRESSION; EARLY IMPROVEMENT; PROMOTER POLYMORPHISM; DOUBLE-BLIND; METAANALYSIS; FLUOXETINE; DISORDER; EFFICACY; AUGMENTATION;
D O I
10.1016/j.pnpbp.2009.12.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The primary objective of this article is to review the literature regarding the speed of response to antidepressant drugs and potential strategies to accelerate the antidepressant response in new antidepressant-free patients with depression. Based on these data, we try to propose both an effective and safe antidepressant treatment strategy to alleviate depressive symptoms at the earliest opportunity. Data sources: Data were identified by searches of Medline (1966 to September 2009) and references from relevant articles and books. Search terms included depression, antidepressant, predictor, response, onset, acceleration, and augmentation. As our focus was on the acute phase treatment of depression, articles relevant to treatment-resistant depression were excluded. Only articles written in English or Japanese were consulted. Data selection: Studies, reviews, and books pertaining to the treatment of depression with a special regard to accelerating therapeutic effects were selected. Data synthesis: Most of the available treatment guidelines for major depressive disorders recommend the continuous use of antidepressants for 4 to 8 weeks based on the idea of a delayed onset of response to these drugs. Contrary to this conventional belief, the recent data indicate that antidepressants start to exert their effects within 2 weeks and early non-response could predict a subsequent unfavorable outcome. Conclusions: These findings suggest the need of revisiting the timing of an antidepressant switch for early non-responders, whereby switching could be commenced in as early as 2 weeks. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 50 条
  • [31] Black and White Patients Response to Antidepressant Treatment for Major Depression
    Roy V. Varner
    Pedro Ruiz
    David R. Small
    Psychiatric Quarterly, 1998, 69 : 117 - 125
  • [32] Tryptophan and tyrosine availability and response to antidepressant treatment in major depression
    Porter, RJ
    Mulder, RT
    Joyce, PR
    Luty, SE
    JOURNAL OF AFFECTIVE DISORDERS, 2005, 86 (2-3) : 129 - 134
  • [33] Race, Genetic Ancestry and Response to Antidepressant Treatment for Major Depression
    Eleanor Murphy
    Liping Hou
    Brion S Maher
    Girma Woldehawariat
    Layla Kassem
    Nirmala Akula
    Gonzalo Laje
    Francis J McMahon
    Neuropsychopharmacology, 2013, 38 : 2598 - 2606
  • [34] Black and white patients response to antidepressant treatment for major depression
    Varner, RV
    Ruiz, P
    Small, DR
    PSYCHIATRIC QUARTERLY, 1998, 69 (02) : 117 - 125
  • [35] Race, Genetic Ancestry and Response to Antidepressant Treatment for Major Depression
    Murphy, Eleanor
    Hou, Liping
    Maher, Brion S.
    Woldehawariat, Girma
    Kassem, Layla
    Akula, Nirmala
    Laje, Gonzalo
    McMahon, Francis J.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (13) : 2598 - 2606
  • [36] IGF-I in major depression and antidepressant treatment response
    Kopczak, Anna
    Stalla, Guenter Karl
    Uhr, Manfred
    Lucae, Susanne
    Hennings, Johannes
    Ising, Marcus
    Holsboer, Florian
    Kloiber, Stefan
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (06) : 864 - 872
  • [37] Glucose metabolic correlates of depression severity and antidepressant treatment response
    Drevets, WC
    Thase, M
    Bogers, W
    Phil, G
    David, KJ
    BIOLOGICAL PSYCHIATRY, 2002, 51 (08) : 176S - 176S
  • [38] A common clinical conundrum: Antidepressant treatment of depression in pregnant women
    Mesches, Gabrielle A.
    Wisner, Katherine L.
    Betcher, Hannah K.
    SEMINARS IN PERINATOLOGY, 2020, 44 (03)
  • [39] EFFECTS OF ANTIDEPRESSANT TREATMENT ON CLINICAL MEASURES OF ATTENTION IN ADOLESCENTS WITH DEPRESSION
    Choi, Chi-Hyun
    Lee, Jung
    Lee, Kyung Hwa
    Hong, Soon-Beom
    Kim, Seong Hae
    Han, Ji Youn
    Kim, Jae-Won
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S239 - S239
  • [40] The influence of clinical features of refractory depression on antidepressant treatment results
    Hese, RT
    Gruszczynski, W
    Szwed, A
    Kielc, M
    Zalitacz, M
    PHARMACOPSYCHIATRY, 2002, 35 (05) : III - III